Purine derivatives and pharmaceutically acceptable salts...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 473/28 (2006.01) A61K 31/52 (2006.01)

Patent

CA 2145432

An object of the present invention is to offer novel purine derivatives which exhibit an inhibitory action to nasal mucus secretion and are useful as pharmaceuticals, etc. and pharma- ceutically acceptable salts thereof. The purine derivatives of the present invention are novel compounds which are represented by the following general formula (I). Image (I) [In the formula, R is alkyl or cycloalkyl, or optionally- substituted phenyl or phenylalkyl; R' is hydrogen or -COOX; and X is alkyl, alkenyl, alkoxyalkyl, phenyl or phenylalkyl] The compounds of the present invention are useful as thera- peutic and preventive agents to various types of rhinitis accom- panied by acceleration of nasal mucus secretion and by sneezing reflex such as allergic rhinitis. Moreover, the compounds of the present invention are able to be administered orally and exhibit low toxicity, little side effect and high safety. Accordingly, a continuous administration for long term is possible and they have a very high utility as the drugs.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Purine derivatives and pharmaceutically acceptable salts... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Purine derivatives and pharmaceutically acceptable salts..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Purine derivatives and pharmaceutically acceptable salts... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1715436

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.